 | • レポートコード：GIR-107A12071 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、82ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、在宅薬物乱用（DOA）検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。在宅薬物乱用（DOA）検査の種類別市場規模（検査カップ、検査ディップカード、検査ストリップ、その他）、用途別市場規模（尿、唾液、髪の毛、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・在宅薬物乱用（DOA）検査の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：UCP Biosciences、Orient New Life Medical、Express Diagnostics Int’l、Assure Tech (Hangzhou)、Psychemedics Corporation、Confirm BioSciences、Phamatech、Home Health (U.K.) Ltd.、Quest Products ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：検査カップ、検査ディップカード、検査ストリップ、その他 ・用途別分析2016年-2026年：尿、唾液、髪の毛、その他 ・在宅薬物乱用（DOA）検査の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・在宅薬物乱用（DOA）検査のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・在宅薬物乱用（DOA）検査のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・在宅薬物乱用（DOA）検査の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・在宅薬物乱用（DOA）検査の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The At-Home Drug of Abuse (DOA) Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global At-Home Drug of Abuse (DOA) Testing size is estimated to be USD 625.8 million in 2026 from USD 425.2 million in 2020, with a change XX% between 2020 and 2021. The global At-Home Drug of Abuse (DOA) Testing market size is expected to grow at a CAGR of 10.1% for the next five years.
Market segmentation
At-Home Drug of Abuse (DOA) Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Test Cups
Test Dip Cards
Test Strips
Others
Market segment by Application, can be divided into
Urine
Saliva
Hair
Others
Market segment by players, this report covers
UCP Biosciences
Orient New Life Medical
Express Diagnostics Int’l
Assure Tech (Hangzhou)
Psychemedics Corporation
Confirm BioSciences
Phamatech
Home Health (U.K.) Ltd.
Quest Products
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe At-Home Drug of Abuse (DOA) Testing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of At-Home Drug of Abuse (DOA) Testing, with revenue, gross margin and global market share of At-Home Drug of Abuse (DOA) Testing from 2019 to 2021.
Chapter 3, the At-Home Drug of Abuse (DOA) Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and At-Home Drug of Abuse (DOA) Testing market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe At-Home Drug of Abuse (DOA) Testing research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Product Overview and Scope of At-Home Drug of Abuse (DOA) Testing
1.2 Classification of At-Home Drug of Abuse (DOA) Testing by Type
1.2.1 Overview: Global At-Home Drug of Abuse (DOA) Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type in 2020
1.2.3 Test Cups
1.2.4 Test Dip Cards
1.2.5 Test Strips
1.2.6 Others
1.3 Global At-Home Drug of Abuse (DOA) Testing Market by Application
1.3.1 Overview: Global At-Home Drug of Abuse (DOA) Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Urine
1.3.3 Saliva
1.3.4 Hair
1.3.5 Others
1.4 Global At-Home Drug of Abuse (DOA) Testing Market Size & Forecast
1.5 Global At-Home Drug of Abuse (DOA) Testing Market Size and Forecast by Region
1.5.1 Global At-Home Drug of Abuse (DOA) Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global At-Home Drug of Abuse (DOA) Testing Market Size by Region, (2016-2021)
1.5.3 North America At-Home Drug of Abuse (DOA) Testing Market Size and Prospect (2016-2026)
1.5.4 Europe At-Home Drug of Abuse (DOA) Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size and Prospect (2016-2026)
1.5.6 South America At-Home Drug of Abuse (DOA) Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa At-Home Drug of Abuse (DOA) Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 At-Home Drug of Abuse (DOA) Testing Market Drivers
1.6.2 At-Home Drug of Abuse (DOA) Testing Market Restraints
1.6.3 At-Home Drug of Abuse (DOA) Testing Trends Analysis
2 Company Profiles
2.1 UCP Biosciences
2.1.1 UCP Biosciences Details
2.1.2 UCP Biosciences Major Business
2.1.3 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.1.4 UCP Biosciences At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 UCP Biosciences Recent Developments and Future Plans
2.2 Orient New Life Medical
2.2.1 Orient New Life Medical Details
2.2.2 Orient New Life Medical Major Business
2.2.3 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.2.4 Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Orient New Life Medical Recent Developments and Future Plans
2.3 Express Diagnostics Int’l
2.3.1 Express Diagnostics Int’l Details
2.3.2 Express Diagnostics Int’l Major Business
2.3.3 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.3.4 Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Express Diagnostics Int’l Recent Developments and Future Plans
2.4 Assure Tech (Hangzhou)
2.4.1 Assure Tech (Hangzhou) Details
2.4.2 Assure Tech (Hangzhou) Major Business
2.4.3 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.4.4 Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Assure Tech (Hangzhou) Recent Developments and Future Plans
2.5 Psychemedics Corporation
2.5.1 Psychemedics Corporation Details
2.5.2 Psychemedics Corporation Major Business
2.5.3 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.5.4 Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Psychemedics Corporation Recent Developments and Future Plans
2.6 Confirm BioSciences
2.6.1 Confirm BioSciences Details
2.6.2 Confirm BioSciences Major Business
2.6.3 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.6.4 Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Confirm BioSciences Recent Developments and Future Plans
2.7 Phamatech
2.7.1 Phamatech Details
2.7.2 Phamatech Major Business
2.7.3 Phamatech At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.7.4 Phamatech At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Phamatech Recent Developments and Future Plans
2.8 Home Health (U.K.) Ltd.
2.8.1 Home Health (U.K.) Ltd. Details
2.8.2 Home Health (U.K.) Ltd. Major Business
2.8.3 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.8.4 Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Home Health (U.K.) Ltd. Recent Developments and Future Plans
2.9 Quest Products
2.9.1 Quest Products Details
2.9.2 Quest Products Major Business
2.9.3 Quest Products At-Home Drug of Abuse (DOA) Testing Product and Solutions
2.9.4 Quest Products At-Home Drug of Abuse (DOA) Testing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Quest Products Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global At-Home Drug of Abuse (DOA) Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 At-Home Drug of Abuse (DOA) Testing Players Market Share
3.2.2 Top 10 At-Home Drug of Abuse (DOA) Testing Players Market Share
3.2.3 Market Competition Trend
3.3 At-Home Drug of Abuse (DOA) Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global At-Home Drug of Abuse (DOA) Testing Revenue and Market Share by Type (2016-2021)
4.2 Global At-Home Drug of Abuse (DOA) Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Application (2016-2021)
5.2 At-Home Drug of Abuse (DOA) Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America At-Home Drug of Abuse (DOA) Testing Revenue by Type (2016-2026)
6.2 North America At-Home Drug of Abuse (DOA) Testing Revenue by Application (2016-2026)
6.3 North America At-Home Drug of Abuse (DOA) Testing Market Size by Country
6.3.1 North America At-Home Drug of Abuse (DOA) Testing Revenue by Country (2016-2026)
6.3.2 United States At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
6.3.3 Canada At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe At-Home Drug of Abuse (DOA) Testing Revenue by Type (2016-2026)
7.2 Europe At-Home Drug of Abuse (DOA) Testing Revenue by Application (2016-2026)
7.3 Europe At-Home Drug of Abuse (DOA) Testing Market Size by Country
7.3.1 Europe At-Home Drug of Abuse (DOA) Testing Revenue by Country (2016-2026)
7.3.2 Germany At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
7.3.3 France At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
7.3.5 Russia At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
7.3.6 Italy At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Market Size by Region
8.3.1 Asia-Pacific At-Home Drug of Abuse (DOA) Testing Revenue by Region (2016-2026)
8.3.2 China At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
8.3.3 Japan At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
8.3.5 India At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
8.3.7 Australia At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America At-Home Drug of Abuse (DOA) Testing Revenue by Type (2016-2026)
9.2 South America At-Home Drug of Abuse (DOA) Testing Revenue by Application (2016-2026)
9.3 South America At-Home Drug of Abuse (DOA) Testing Market Size by Country
9.3.1 South America At-Home Drug of Abuse (DOA) Testing Revenue by Country (2016-2026)
9.3.2 Brazil At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Market Size by Country
10.3.1 Middle East & Africa At-Home Drug of Abuse (DOA) Testing Revenue by Country (2016-2026)
10.3.2 Turkey At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
10.3.4 UAE At-Home Drug of Abuse (DOA) Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global At-Home Drug of Abuse (DOA) Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global At-Home Drug of Abuse (DOA) Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market At-Home Drug of Abuse (DOA) Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global At-Home Drug of Abuse (DOA) Testing Revenue (USD Million) by Region (2016-2021)
Table 5. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Region (2021-2026)
Table 6. UCP Biosciences Corporate Information, Head Office, and Major Competitors
Table 7. UCP Biosciences Major Business
Table 8. UCP Biosciences At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 9. UCP Biosciences At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Orient New Life Medical Corporate Information, Head Office, and Major Competitors
Table 11. Orient New Life Medical Major Business
Table 12. Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 13. Orient New Life Medical At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Express Diagnostics Int’l Corporate Information, Head Office, and Major Competitors
Table 15. Express Diagnostics Int’l Major Business
Table 16. Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 17. Express Diagnostics Int’l At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Assure Tech (Hangzhou) Corporate Information, Head Office, and Major Competitors
Table 19. Assure Tech (Hangzhou) Major Business
Table 20. Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 21. Assure Tech (Hangzhou) At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Psychemedics Corporation Corporate Information, Head Office, and Major Competitors
Table 23. Psychemedics Corporation Major Business
Table 24. Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 25. Psychemedics Corporation At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Confirm BioSciences Corporate Information, Head Office, and Major Competitors
Table 27. Confirm BioSciences Major Business
Table 28. Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 29. Confirm BioSciences At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Phamatech Corporate Information, Head Office, and Major Competitors
Table 31. Phamatech Major Business
Table 32. Phamatech At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 33. Phamatech At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Home Health (U.K.) Ltd. Corporate Information, Head Office, and Major Competitors
Table 35. Home Health (U.K.) Ltd. Major Business
Table 36. Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 37. Home Health (U.K.) Ltd. At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Quest Products Corporate Information, Head Office, and Major Competitors
Table 39. Quest Products Major Business
Table 40. Quest Products At-Home Drug of Abuse (DOA) Testing Product and Solutions
Table 41. Quest Products At-Home Drug of Abuse (DOA) Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global At-Home Drug of Abuse (DOA) Testing Revenue (USD Million) by Players (2019-2021)
Table 43. Global At-Home Drug of Abuse (DOA) Testing Revenue Share by Players (2019-2021)
Table 44. Breakdown of At-Home Drug of Abuse (DOA) Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. At-Home Drug of Abuse (DOA) Testing Players Head Office, Products and Services Provided
Table 46. At-Home Drug of Abuse (DOA) Testing Mergers & Acquisitions in the Past Five Years
Table 47. At-Home Drug of Abuse (DOA) Testing New Entrants and Expansion Plans
Table 48. Global At-Home Drug of Abuse (DOA) Testing Revenue (USD Million) by Type (2016-2021)
Table 49. Global At-Home Drug of Abuse (DOA) Testing Revenue Share by Type (2016-2021)
Table 50. Global At-Home Drug of Abuse (DOA) Testing Revenue Forecast by Type (2021-2026)
Table 51. Global At-Home Drug of Abuse (DOA) Testing Revenue by Application (2016-2021)
Table 52. Global At-Home Drug of Abuse (DOA) Testing Revenue Forecast by Application (2021-2026)
Table 53. North America At-Home Drug of Abuse (DOA) Testing Revenue by Type (2016-2021) & (USD Million)
Table 54. North America At-Home Drug of Abuse (DOA) Testing Revenue by Type (2021-2026) & (USD Million)
Table 55. North America At-Home Drug of Abuse (DOA) Testing Revenue by Application (2016-2021) & (USD Million)
Table 56. North America At-Home Drug of Abuse (DOA) Testing Revenue by Application (2021-2026) & (USD Million)
Table 57. North America At-Home Drug of Abuse (DOA) Testing Revenue by Country (2016-2021) & (USD Million)
Table 58. North America At-Home Drug of Abuse (DOA) Testing Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe At-Home Drug of Abuse (DOA) Testing Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe At-Home Drug of Abuse (DOA) Testing Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe At-Home Drug of Abuse (DOA) Testing Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe At-Home Drug of Abuse (DOA) Testing Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe At-Home Drug of Abuse (DOA) Testing Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe At-Home Drug of Abuse (DOA) Testing Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Revenue by Region (2021-2026) & (USD Million)
Table 71. South America At-Home Drug of Abuse (DOA) Testing Revenue by Type (2016-2021) & (USD Million)
Table 72. South America At-Home Drug of Abuse (DOA) Testing Revenue by Type (2021-2026) & (USD Million)
Table 73. South America At-Home Drug of Abuse (DOA) Testing Revenue by Application (2016-2021) & (USD Million)
Table 74. South America At-Home Drug of Abuse (DOA) Testing Revenue by Application (2021-2026) & (USD Million)
Table 75. South America At-Home Drug of Abuse (DOA) Testing Revenue by Country (2016-2021) & (USD Million)
Table 76. South America At-Home Drug of Abuse (DOA) Testing Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa At-Home Drug of Abuse (DOA) Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. At-Home Drug of Abuse (DOA) Testing Picture
Figure 2. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Type in 2020
Figure 3. Test Cups
Figure 4. Test Dip Cards
Figure 5. Test Strips
Figure 6. Others
Figure 7. At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Application in 2020
Figure 8. Urine Picture
Figure 9. Saliva Picture
Figure 10. Hair Picture
Figure 11. Others Picture
Figure 12. Global At-Home Drug of Abuse (DOA) Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global At-Home Drug of Abuse (DOA) Testing Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Region (2016-2026)
Figure 15. Global At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Region in 2020
Figure 16. North America At-Home Drug of Abuse (DOA) Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe At-Home Drug of Abuse (DOA) Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America At-Home Drug of Abuse (DOA) Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. At-Home Drug of Abuse (DOA) Testing Market Drivers
Figure 22. At-Home Drug of Abuse (DOA) Testing Market Restraints
Figure 23. At-Home Drug of Abuse (DOA) Testing Market Trends
Figure 24. UCP Biosciences Recent Developments and Future Plans
Figure 25. Orient New Life Medical Recent Developments and Future Plans
Figure 26. Express Diagnostics Int’l Recent Developments and Future Plans
Figure 27. Assure Tech (Hangzhou) Recent Developments and Future Plans
Figure 28. Psychemedics Corporation Recent Developments and Future Plans
Figure 29. Confirm BioSciences Recent Developments and Future Plans
Figure 30. Phamatech Recent Developments and Future Plans
Figure 31. Home Health (U.K.) Ltd. Recent Developments and Future Plans
Figure 32. Quest Products Recent Developments and Future Plans
Figure 33. Global At-Home Drug of Abuse (DOA) Testing Revenue Share by Players in 2020
Figure 34. At-Home Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players At-Home Drug of Abuse (DOA) Testing Revenue Market Share in 2020
Figure 36. Global Top 10 Players At-Home Drug of Abuse (DOA) Testing Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global At-Home Drug of Abuse (DOA) Testing Revenue Share by Type in 2020
Figure 39. Global At-Home Drug of Abuse (DOA) Testing Market Share Forecast by Type (2021-2026)
Figure 40. Global At-Home Drug of Abuse (DOA) Testing Revenue Share by Application in 2020
Figure 41. Global At-Home Drug of Abuse (DOA) Testing Market Share Forecast by Application (2021-2026)
Figure 42. North America At-Home Drug of Abuse (DOA) Testing Sales Market Share by Type (2016-2026)
Figure 43. North America At-Home Drug of Abuse (DOA) Testing Sales Market Share by Application (2016-2026)
Figure 44. North America At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Country (2016-2026)
Figure 45. United States At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe At-Home Drug of Abuse (DOA) Testing Sales Market Share by Type (2016-2026)
Figure 49. Europe At-Home Drug of Abuse (DOA) Testing Sales Market Share by Application (2016-2026)
Figure 50. Europe At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Country (2016-2026)
Figure 51. Germany At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Region (2016-2026)
Figure 59. China At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America At-Home Drug of Abuse (DOA) Testing Sales Market Share by Type (2016-2026)
Figure 66. South America At-Home Drug of Abuse (DOA) Testing Sales Market Share by Application (2016-2026)
Figure 67. South America At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Country (2016-2026)
Figure 68. Brazil At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa At-Home Drug of Abuse (DOA) Testing Revenue Market Share by Country (2016-2026)
Figure 73. Turkey At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE At-Home Drug of Abuse (DOA) Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界の乱用薬物（DOA）実験用消耗品市場 2021：企業別、地域別、種類・用途別 The Drug of Abuse (DOA) Testing Consumables market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizatio…- 世界の乱用薬物（DOA）実験用装置市場 2021：企業別、地域別、種類・用途別 The Drug of Abuse (DOA) Testing Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 世界の乱用薬物検査市場 2021：企業別、地域別、種類・用途別 The Drugs of Abuse Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界の薬物検査システム市場 2021：企業別、地域別、種類・用途別 The Drug Testing System market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations…
- 世界の路上用薬物検査装置市場 2021：企業別、地域別、種類・用途別 The Roadside Drug Testing Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade re…